Add to Favorites Newsroom RSS Share
fb-shareRutgers Cancer Institute of New Jersey
New Brunswick, NJ USA

Our News on Newswise

Cervical Cancer Awareness Month

January is Cervical Cancer Awareness Month. A Rutgers Cancer Institute of New Jersey expert shares insight on prevention and early detection of this disease.
2-Jan-2020 3:00 PM EST Add to Favorites

New Year's Resolution: Quitting Smoking

An expert from the Rutgers Tobacco Dependence Program shares info and resources on how to quit smoking in the new year.
17-Dec-2019 10:15 AM EST Add to Favorites

Newswise: Evens_Andrew_2_SH_Sp2019.jpg

Novel Cell-Based Therapy Induces Cell Death in Sensitive and Resistant Non-Hodgkin Lymphoma Models

Investigators at Rutgers Cancer Institute of New Jersey have found that a treatment based on a novel cellular product programmed to deliver an overabundance of chimeric antigen receptor causes cell death in non-Hodgkin lymphoma models that are...
16-Dec-2019 8:05 AM EST Add to Favorites

Newswise: HafftyBruce2080NR0116.jpg

Analysis of Different Treatment Strategies for Non-Invasive Breast Cancer Shows Radiation Treatment Alone is Cost-Effective

Rutgers Cancer Institute of New Jersey investigators evaluated all treatment strategies for both standard-risk and good-risk ductal carcinoma in-situ and found the most commonly recommended combination treatment for DCIS represents low-value care,...
11-Dec-2019 2:05 PM EST Add to Favorites

Newswise: Kritharis_Athena_2_SP2018SH.jpg

Small Mutations Identified through Deep DNA Sequencing for AML and MDS

Deep DNA sequencing analysis conducted by Rutgers Cancer Institute of New Jersey investigators examining genomic differences within tumors for prediction of disease relapse in certain hematologic malignancies has identified small mutations. These...
9-Dec-2019 5:05 PM EST Add to Favorites

Newswise: OhriNisha18.jpg

Retrospective Analysis Shows Proton Therapy Well Tolerated in Patients Undergoing Breast Conserving Surgery

Investigators at Rutgers Cancer Institute of New Jersey conducted a retrospective review of patients treated with proton therapy following breast-conserving surgery and found acceptable toxicity rates along with good-to-excellent patient-reported...
9-Dec-2019 4:20 PM EST Add to Favorites

Newswise: Moerdler_Scott.jpg

Likelihood of Prenatal Screening for Blood Disorders Varies Between Type of Healthcare Provider

A Rutgers Cancer Institute of New Jersey investigator and other collaborators examined prenatal screening practices for blood disorders between different types of care providers and found different variations in prenatal guidance.
5-Dec-2019 9:00 AM EST Add to Favorites

Newswise: Cooper.jpg

Addition of Post-Transplant Chemotherapy to Standard Immune Treatment Shows Increase of Allogeneic Transplant Patients in Remission

Rutgers Cancer Institute of New Jersey investigators compared outcomes for allogeneic stem cell transplant patients when post-transplant cyclophosphamide (PCy) was added as part of standard treatment than if standard treatment was given alone....
5-Dec-2019 8:45 AM EST Add to Favorites

see all news

Our Experts on Newswise

Newswise: IMG_2298PREFERRED.jpg

Oncology Pharmacists: An Essential Partner in the Cancer Journey

One of the hallmarks of a National Cancer Institute-designated Comprehensive Cancer Center is the unique oncology expertise exhibited by its clinical team, including board certified oncology pharmacists. A Rutgers Cancer Institute of New Jersey...
18-Oct-2019 8:00 AM EDT

Newswise: shicha-kumar.png

Lumpectomy for Breast Cancer with Attention to Cosmetic Results

As more women live with breast cancer, minimization of significant deformity in the breast after breast preservation is increasingly gaining attention. A Rutgers Cancer Institute of New Jersey surgical oncologist shares some insight.
25-Sep-2019 2:05 PM EDT

Newswise: Kritharis_Athena_1_SP2018.jpg

Leukemia: Not Just One Disease

An estimated 61,780 new cases of leukemia will be diagnosed in the United States this year. Although leukemias are thought to occur in childhood, they can actually present at any age in both children and adults.
30-Aug-2019 8:05 AM EDT

Newswise: screening50scouplewdocrelease.jpg

Colorectal Cancer: Advancing Awareness

Colorectal cancer is the third leading cancer in both new cases and cancer deaths in the United States. While colorectal cancer incidence declined 3.7 percent annually from 2006 to 2015 for those 55 and older, rates have increased 1.8 percent...
18-Mar-2019 3:05 PM EDT

Newswise: lungartredshutterstock_5325632082.jpg

A New Tool to Help Fight an Old Enemy – Lung Cancer

In the U.S., lung cancer remains the leading cause of cancer death among both men and women. The primary reason for high death rates for lung cancer is the fact that this disease is typically detected in very late stages. A Rutgers University expert...
30-Oct-2018 5:05 PM EDT

Newswise: sicklecell18card-1-L.jpg

September is Sickle Cell Disease Awareness Month

Sickle cell disease is a common inherited blood disorder, affecting an estimated 100,000 Americans of different racial and ethnic groups. A Rutgers Cancer Institute of New Jersey expert shares more about the importance of early diagnosis and...
24-Sep-2018 8:00 AM EDT

Newswise: thyroidpuzzleshutterstock_342277517.jpg

Thyroid Cancer 101

While thyroid cancers are common, they may not be as widely understood as other common cancers such as breast or prostate. A Rutgers Cancer Institute of New Jersey expert shares more about the butterfly-shaped gland in the lower neck and how...
18-Sep-2018 8:00 AM EDT

Newswise: womenmulticulturalshutterstock_583329955.jpg

Ovarian Cancer: What You Need to Know

During this Gynecologic Cancers Awareness Month, a Rutgers Cancer Institute of New Jersey expert shares info on symptoms and treatment of ovarian cancer.
14-Sep-2018 12:00 PM EDT

see all experts

Our YouTube Videos


As New Jersey’s only National Cancer Institute-designated Comprehensive Cancer Center, Rutgers Cancer Institute of New Jersey is dedicated to improving the prevention, detection, treatment, and care of patients with cancer, through the transformation of laboratory discoveries into clinical practice. Rutgers Cancer Institute of New Jersey delivers advanced comprehensive care to adults and children including access to clinical trials and conducts cutting-edge cancer research.

The coveted NCI designation, awarded to only 47 such centers nationwide, is granted competitively to institutions characterized by scientific excellence and the ability to bring research discoveries to patients. To gain a "comprehensive" designation, the highest ranking given by the NCI, a center must meet rigorous criteria in cancer care, research, prevention and education.

The leadership of Rutgers Cancer Institute is comprised of distinguished researchers and physicians who are internationally recognized in their field. Basic scientists, clinical researchers, and population scientists meet regularly to exchange information and ensure that laboratory discoveries are refined and applied to clinical care as quickly as possible, that clinical observations reach laboratory researchers on a continuing basis, and that prevention strategies are interwoven in to all research programs.


  • Andrew M. Evens

    DO, MSc

    Oncologist, Lymphoma (Hodgkin lymphoma and non-Hodgkin lymphoma), Blood Disorders, Blood Cancer, Leukemia, Hematology
  • Keywords:
    Oncology, Medical Oncology, cancer clinical research


Main Box
Program Assistant


Sue Caputo
Program Assistant


Michele Fisher
Public Relations Manager


Twitter twitter-icon

Chat now!